RENALYTIX PLC
AI diagnostics platform assessing kidney disease progression risk in diabetic patients.
RENX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYWL4Y04 (+1 more)
- LEI:
- 213800NTOH3FK3WER551
- Country:
- United Kingdom
- Address:
- 2 LEMAN STREET, E1W 9US LONDON
- Website:
- https://renalytix.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on optimizing the clinical management of kidney disease. The company develops bioprognostic solutions to assess the risk of disease progression. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized testing platform that provides a risk score for the progressive decline of kidney function in adults with type 2 diabetes and early-stage chronic kidney disease (CKD). By enabling early risk identification, the platform helps clinicians and healthcare systems target resources and guideline-recommended treatments to improve patient outcomes and slow disease advancement. The company partners with health systems, insurers, and pharmaceutical companies to implement its technology.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for RENALYTIX PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-17 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.9 KB | |
| 2025-09-16 19:26 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.1 KB | |
| 2025-09-16 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB | |
| 2025-09-15 08:00 |
Regulatory News Service
Tempus AI Inc, collaboration agreement
|
English | 21.2 KB | |
| 2025-09-10 17:32 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.2 KB | |
| 2025-09-02 13:46 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.7 KB | |
| 2025-08-22 18:11 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.5 KB | |
| 2025-08-22 14:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.8 KB | |
| 2025-07-29 08:00 |
Regulatory News Service
Services contract with Joslin and Pharma Partner
|
English | 17.2 KB | |
| 2025-07-17 08:01 |
Regulatory News Service
Partnership with MVP Health Care
|
English | 16.3 KB | |
| 2025-07-17 08:00 |
Board/Management Information
Change of Adviser
|
English | 13.4 KB | |
| 2025-06-27 14:09 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.4 KB | |
| 2025-06-26 12:48 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.6 KB | |
| 2025-06-03 08:00 |
Business and Financial Review
Growing collaboration with NYKHM
|
English | 19.2 KB | |
| 2025-05-30 13:38 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.7 KB |
Automate Your Workflow. Get a real-time feed of all RENALYTIX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for RENALYTIX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
